JFS Wealth Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-226
Closed -$22K 565
2019
Q3
$22K Hold
226
0.01% 294
2019
Q2
$21K Hold
226
0.01% 303
2019
Q1
$21K Buy
226
+130
+135% +$11.4K 0.01% 296
2018
Q4
$6K Hold
96
﹤0.01% 386
2018
Q3
$9K Hold
96
﹤0.01% 424
2018
Q2
$8K Sell
96
-19
-17% -$1.58K ﹤0.01% 388
2018
Q1
$10K Buy
115
+95
+475% +$9.12K ﹤0.01% 371
2017
Q4
$2K Buy
20
+19
+1,900% +$2.14K ﹤0.01% 497
2017
Q3
$0 Hold
1
﹤0.01% 470
2017
Q2
$0 Buy
+1
New +$123 ﹤0.01% 480
2016
Q2
Sell
-24
Closed -$2K 670
2016
Q1
$2K Buy
+24
New +$2.47K ﹤0.01% 545
2015
Q3
Sell
-44
Closed -$5K 618
2015
Q2
$5K Sell
44
-8
-15% -$915 ﹤0.01% 415
2015
Q1
$6K Sell
52
-68
-57% -$8.13K ﹤0.01% 410
2014
Q4
$13K Buy
120
+67
+126% +$7.07K ﹤0.01% 350
2014
Q3
$5K Sell
53
-7
-12% -$632 ﹤0.01% 388
2014
Q2
$5K Buy
+60
New +$4.56K ﹤0.01% 385

Other funds holding CELG

JFS Wealth Advisors's CELG Position: Q4 2019 in Review

JFS Wealth Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 226 shares — an estimated $22K sold.

JFS Wealth Advisors first reported a position in CELG in Q2 2014 and held it in 16 quarters. The position peaked at $22K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • JFS Wealth Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • JFS Wealth Advisors sold 226 Celgene Corp shares in Q4 2019, an estimated $22K.
  • JFS Wealth Advisors first reported a position in Celgene Corp in Q2 2014 and held it in 16 quarters.
  • JFS Wealth Advisors's Celgene Corp position peaked at $22K in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on JFS Wealth Advisors's 13F filing for Q4 2019, filed 3 Feb 2020.